Research-Grade Erythropoietin for Cellular Studies
Eprex 2000IU Janssen-Cilag is a recombinant human erythropoietin (rHuEPO) pharmaceutical preparation manufactured under strict GMP conditions for laboratory research applications. This glycoprotein hormone represents the bioengineered equivalent of endogenous erythropoietin, enabling researchers to investigate haematopoietic pathways, cellular differentiation mechanisms, and erythroid progenitor cell development in controlled experimental environments.
Research scientists examining erythropoiesis regulation can utilise this formulation to study the molecular mechanisms underlying red blood cell production, investigating how EPO receptor signalling cascades influence cellular proliferation and differentiation. The pharmaceutical-grade preparation ensures consistent potency for reproducible experimental outcomes across haematology research protocols. Stroid UK Shop studying anaemia-related cellular mechanisms frequently employ erythropoietin preparations to evaluate therapeutic pathways and cellular responses.
Laboratory Applications and Research Protocols
This erythropoietin preparation facilitates comprehensive investigation of haematopoietic stem cell biology, allowing researchers to examine how EPO signalling influences cellular fate determination and erythroid lineage commitment. Laboratory studies can evaluate the glycoprotein’s role in modulating apoptosis, cellular proliferation rates, and differentiation marker expression in various cell culture systems. Advanced research protocols utilise EPO preparations to investigate neuroprotective mechanisms, as erythropoietin receptors are expressed in neural tissues beyond haematopoietic compartments.
Cardiovascular research applications include studying EPO’s influence on endothelial cell function, angiogenesis pathways, and vascular protection mechanisms. Researchers examining hormone-based therapeutic compounds can investigate how erythropoietin modulates cellular signalling cascades involved in tissue protection and repair mechanisms. Cell biology laboratories study EPO’s anti-apoptotic properties and its influence on cellular stress responses. Additionally, research teams exploring selective receptor modulators and bioactive peptides often compare EPO’s receptor-mediated effects with other signalling compounds.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Recombinant Human Erythropoietin |
| Potency | 2000 International Units |
| Manufacturer | Janssen-Cilag |
| Formulation | Sterile solution for injection |
| Storage Conditions | 2-8°C, protect from light |
| Molecular Weight | ~30.4 kDa |
| CAS Number | Verify with supplier |
Research Compliance and Laboratory Use
This erythropoietin preparation is exclusively intended for qualified research institutions conducting in-vitro studies and laboratory investigations. The product must be handled according to institutional biosafety protocols and stored under appropriate pharmaceutical-grade conditions. Researchers should verify compatibility with their specific experimental protocols and ensure proper documentation of handling procedures. This product is not intended for human consumption, clinical application, or therapeutic use outside authorised laboratory research settings.
